
[Expand/Collapse all sections]Expand all

This document outlines details of the Pharmaceutical Benefits Scheme
(PBS) subsidised polylactic acid for patients with severe facial
lipoatrophy, only as a result of therapy for HIV infection.

Severe facial lipoatrophy and listing dates

Polylactic acid is an injectable liquid used to add volume to areas of
the face to create a soft, natural, more youthful re-contouring of the
face from severe facial lipoatrophy caused by therapy for HIV infection
only. It builds the body's own collagen while it gradually disappears.

Listing dates are as follows:

-   polylactic acid - 1 September 2009

See Written Authority Required Drugs for further information.

Enquiries

Transfer enquiries about prescription arrangements to the Complex Drugs
Programs team and choose the team relevant to the condition being
treated.

The Resources page contains links to restriction and item codes, contact
details, the Pharmaceutical Benefits Scheme (PBS) and Services Australia
websites, and frequently asked questions.

Related links

Written Authority Required Drugs

Process Telephone Authority Approval Application

                                   

-   Services Australia ABN 90 794 605 008 
